Literature DB >> 19260782

Clinical study of mild hypothermia treatment for severe traumatic brain injury.

Ji-Yao Jiang1.   

Abstract

Clinical randomized controlled trials (RCTs) suggest that mild hypothermia may improve the outcome of severe traumatic brain injured patients with intracranial hypertension when cooling is maintained for longer than 48 h. However, the results are not yet conclusive, and more RCTs are required. Mild hypothermia significantly decreases intracranial pressure (ICP) values when refractory intracranial hypertension cannot be controlled by conventional measures in patients with severe traumatic brain injury (TBI). Prolonged mild-to-moderate hypothermia may be associated with high incidence of pneumonia and hypokalemia, which should be prevented.

Entities:  

Mesh:

Year:  2009        PMID: 19260782     DOI: 10.1089/neu.2008.0525

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  10 in total

1.  The Use of Hypothermia Therapy in Traumatic Ischemic / Reperfusional Brain Injury: Review of the Literatures.

Authors:  Shoji Yokobori; Janek Frantzen; Ross Bullock; Shyam Gajavelli; Stephen Burks; Helen Bramlett; W Dalton Dietrich
Journal:  Ther Hypothermia Temp Manag       Date:  2011-12-20       Impact factor: 1.286

2.  Moderate Hypothermia Significantly Decreases Hippocampal Cell Death Involving Autophagy Pathway after Moderate Traumatic Brain Injury.

Authors:  Yichao Jin; Yingying Lin; Jun-feng Feng; Feng Jia; Guo-yi Gao; Ji-yao Jiang
Journal:  J Neurotrauma       Date:  2015-05-05       Impact factor: 5.269

3.  Neuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma decompression model.

Authors:  Shoji Yokobori; Shyam Gajavelli; Stefania Mondello; Jixiang Mo-Seaney; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  J Neurosurg       Date:  2012-11-09       Impact factor: 5.115

4.  Combinational therapy using hypothermia and the immunophilin ligand FK506 to target altered pial arteriolar reactivity, axonal damage, and blood-brain barrier dysfunction after traumatic brain injury in rat.

Authors:  Yasutaka Oda; Guoyi Gao; Enoch P Wei; John T Povlishock
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-15       Impact factor: 6.200

5.  Mild hyperthermia worsens the neuropathological damage associated with mild traumatic brain injury in rats.

Authors:  Atsushi Sakurai; Coleen M Atkins; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2012-01-20       Impact factor: 5.269

6.  The adverse pial arteriolar and axonal consequences of traumatic brain injury complicated by hypoxia and their therapeutic modulation with hypothermia in rat.

Authors:  Guoyi Gao; Yasutaka Oda; Enoch P Wei; John T Povlishock
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

7.  Regional hypothermia inhibits spinal cord somatosensory-evoked potentials without neural damage in uninjured rats.

Authors:  Ning Li; Lei Tian; Wei Wu; Huchen Lu; Yuan Zhou; Xiaoyu Xu; Xiangsheng Zhang; Huilin Cheng; Lihua Zhang
Journal:  J Neurotrauma       Date:  2013-07-16       Impact factor: 5.269

Review 8.  A Systematic Review of the Effects of Body Temperature on Outcome After Adult Traumatic Brain Injury.

Authors:  Lori Kennedy Madden; Holli A DeVon
Journal:  J Neurosci Nurs       Date:  2015-08       Impact factor: 1.230

9.  Mild hypothermia for treatment of diffuse axonal injury: a quantitative analysis of diffusion tensor imaging.

Authors:  Guojie Jing; Xiaoteng Yao; Yiyi Li; Yituan Xie; Wang X2019 An Li; Kejun Liu; Yingchao Jing; Baisheng Li; Yifan Lv; Baoxin Ma
Journal:  Neural Regen Res       Date:  2014-01-15       Impact factor: 5.135

Review 10.  Therapeutic hypothermia and targeted temperature management for traumatic brain injury: Experimental and clinical experience.

Authors:  W Dalton Dietrich; Helen M Bramlett
Journal:  Brain Circ       Date:  2017-12-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.